Rene Russo, PRESIDENT AND CEO at Xilio Therapeutics, Inc. (XLO), bought 36,289 shares at $0.68 ($25K) on 2025-06-16, disclosed to the SEC on 2025-06-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.